2 studies found for:    RETAIN Trial—Drug: Alpha 1 Antitrypsin
Show Display Options
Rank Status Study
1 Not yet recruiting A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP);   Drug: Placebo
2 Suspended A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Alpha 1-Antitrypsin;   Biological: Alpha-1 Antitrypsin

Indicates status has not been verified in more than two years